US 9896484
Influenza virus recombinant proteins
granted A61KA61K2039/55566A61K2039/575
Quick answer
US patent 9896484 (Influenza virus recombinant proteins) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/55566, A61K2039/575, A61K39/00, A61K39/12